Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

NCT06649955 is registered in ClinicalTrials.gov with PathMaker Neurosystems Inc. as lead sponsor.

NCT NCT06649955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
Lead sponsor
PathMaker Neurosystems Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
February 10, 2025
Completion date
February 28, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als - amyotrophic lateral sclerosis